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The formation of nonimmune rosettes with sheep erythrocytes (E)' is a
dynamic, energy dependent function (1) of human T lymphocytes. Itis subjectto
modulation by intracellular cyclic nucleotide levels (2, 3) and requires intact
glycolytic (4), protein, and nucleic acid (5) synthetic pathways for full expres-
sion. It is therefore reasonable to suspect that E rosette function may be
susceptible to inhibition by in vivo events which influence these metabolic
pathways . Defective T lymphocyte E rosette function is observed in association
with several diseases including cancer (6), autoimmune diseases (7), and viral
infections (6); however, the specific mechanisms responsible for the observed
defects of E rosette function in these diseases have not been established.
The hepatitis B virus may lead to either transient or persistent infection, and
the associated diseases appear to be mediated by the host response (8). During
hepatitis B virus infection a subpopulation of T lymphocytes, functionally
deficient in respect to E rosette function and lacking easily identifiable surface
membrane immunoglobulin, has been consistently observed.2, 3 Two independ-
ent mechanisms appear to be associated with the generation of functionally
defective T lymphocytes during viral hepatitis B. One mechanism, associated
with persistent hepatitis, appears to be mediated by serum factor(s) extrinsic to
the lymphocyte, and such cells have been referred to as extrinsic null cells.'
These cells reacquire normal E rosette function when cultured in normal serum.
Cultivation ofnormal lymphocytes with serum from patients with extrinsic null
cells induces a similar functional defect in E rosette function (9). The factor
responsible for induction of defective E rosette function we have designated
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rosette inhibitory factor, RIF. It is nondialyzable, stable upon heating to 56°C for
30 min, not a complement dependent lymphocytotoxic antibody, physically
separable from HBsAg, and is of low density.'
In the present study RIF has been isolated andcharacterized, andthe effect of
this factor on certain lymphocyte functions is described. RIF appears to repre-
sent a unique species of low-density lipoprotein (LDL) which binds to lympho-
cytes and induces attentuated E rosette function secondary to modulation of
cellular events. RIF appears to selectively suppress certain T lymphocyte func-
tions including E rosette function and to a lesser degree the capacity to respond
in mixed lymphocyte reactions.
Materials and Methods
Sera .
￿
Blood wascollected from young, otherwise healthy adult men with acute viralhepatitis
B andfrom age and sex matched controls previously described.3
Serum waspromptly removed by centrifugation andstored at -20°C. RIF+ and RIF- sera were
used individually, and aliquots were combined to form independent pools.
Lymphocytes.
￿
Lymphocytes were isolated from the peripheral blood of normal donors accord-
ingto the method of Boyum (10) by centrifugation at 20°C and 425g onto abarrier of nine parts 8
g1100ml Ficoll (Sigma Chemical Co., St. Louis, Mo.) and twoparts50% Hypaque (Winthrop Labs.,
New York, NY) adjusted to a density of 1.074 g/ml (refractive index 1.3470) with 8% Ficoll. The
cellsat the interface were washed twice in RPMI-1640(Grand Island Biological Co., GrandIsland,
N. Y.) at 250gfor 10 min, and totalleukocytecount, differential count, and viability (trypanblue
exclusion) were determined. Absolute yieldoflymphocytes was >75% with 99-100% viability and
>90% purity.
RIF Assay.
￿
Lymphocytes were suspended at 1.5 x 106/ml in RPMI-1640 supplemented with
penicillin (100 U/ml), streptomycin (50 gg/ml), and L-glutamine (2 mM) (Flow Laboratories, Inc.,
Rockville, Md.). Cells were dispensed in 200 pl aliquots into sterile tissue culture plates with flat
bottom wells (Microtest II, Falcon Plastics, Oxnard, CA) containing 50 Al of whole serum or
fractions. When fractions were assayed, complete culture media supplemented with 20% heat
inactivated fetal calf serum (Flow Laboratories, Inc.) was used. When whole human serum was
assayed the sample served as the protein source. Culture plates were covered with loose fitting
sterile lids and incubated for 18 h at 37°C in ahumid atmosphere containing 5% CO2 in air.
For assay of percent E rosette positive lymphocyte, cellswere gently suspended, transferred to
V-bottom microtiter plates (Cooke Engineering, Alexandria, Va.), and washed three times with
200 p,l RPMI-1640 by centrifugation at 200g for3 min. After the last wash all but 50 Al of RPMI-
1640 was removed, and 50 wl of a thrice washed 1.25% suspension of fresh E in RPMI-1640 was
added. The plate was sealed, incubated for 10 min at 37°C, centrifuged for 2 min at 200g, and
incubated 18 hat 4°C. 5 ;al of 0.02% trypan blue was added, and the pellet wasgently aspirated and
transferred to a microslide. Viability was always greater than 95%. 400 viable lymphocytes were
countedand scored as previously described (2). Thearithmetic mean wascalculated from duplicate
assays and accepted if the SD was less than ±5%.
Results were expressed as relative percent inhibition of E rosette positive cells induced by test
serum or serum fraction as compared to control and were calculated:
inhibition (%) = C - X x 100,
C
whereC equals percent E rosette positive lymphocytes cultured in control sample (60-75%) andX
equals percent E rosette positive lymphocytes following culture in test sample. Unless otherwise
stated both phosphate-buffered saline (PBS) andautologous serumserved as controls in all assays,
and percent rosette positive cells in both control assays agreed within ±2.0%. Experiments were
performedin duplicate, andsignificant inhibition wasconsidered to be presentifC differed from X
by at least 2 SD.1094
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Single Analytical Flotation andIsopycnic Banding.
￿
1.5 ml of serum was adjusted to a density
of 1.15 g/cm3 with KBr, placed in a 5-ml ultracentrifuge tube, andoverlaid with 1.5 ml of 0.14 M
NaCl, 0.01 M sodium phosphate, pH 7.3 PBS adjusted to a density of 1 .10 with KBr. Thetube was
then filled with 2.0 ml of PBS and centrifuged in a Spinco SW-50.1 rotor (Beckman Instruments,
Spinco Div., Palo Alto, Calif.) at 189,000 g average for 18 h at 20°C . Six 0.8-ml fractions were
collected sequentially from the tops of tubes and dialyzed against three changes of 100 vol of PBS
for 24 h. Aliquots were analyzed for RIF activity, lipoproteins, serum proteins, and hepatitis B
virus surface antigen (HBsAg).
RIF` fractions were pooled, adjusted to a density of 1.063 g/cm3 with KBr, and subjected to
isopycnic density gradient ultracentrifugation in a Spinco SW-50.1 rotor at 114,000g average for 72
hand 20°C. Serial fractions of0.2 ml were collected from thetop, andabsorbance wasmonitored at
280 nm. The density offractions wascalculated from refractive index . Fractions were dialyzed and
characterized as above.
Lipoprotein Isolation by Sequential Flotation . Conventional lipoprotein classes of defined
density were isolated from pools of RIF+ and RIF- sera by sequential flotation according to the
method of Hatch and Lees (11).
Analytical Sequential Isopycnic Ultracentrifugation.
￿
The density of RIF was estimated by
sequential isopycnic density gradient ultracentrifugation of RIF+ very-low density lipoprotein
(VLDL) plus LDL derived by sequential flotation. Samples were adjusted to 1 .050 g/cm3 with KBr
andcentrifuged in a SW-50.1 rotor at 217,000g average for 74 hat 18°C . Fractions were collected as
above, and absorbance at 280 nm, refractive index, and RIF activity were measured.
Preparative Isopycnic Density Gradient Ultracentrifugation .
￿
200 ml ofserumwasadjusted to a
density of 1.10 g/cm3 with KBr, and 5-ml aliquots were layered under 7 .0 ml of PBSadjusted to 1.05
g/cm3 with KBr and centrifuged in a SW-41 rotor at 149,800 g average for 65 h at 18°C. Fractions
(0.4 ml) were collected, and absorbance at 280 nm andrefractive index were monitored. Fractions
with adensity less than 1 .060 g/cm3 were pooled, adjusted to 1 .050 g/cm3, and centrifuged in a SW-
50.1 rotor at 80,000g average for 65 hat 18°C. Fractions (0.2 ml) with a density between 1.040 and
1 .060 g/cm3 were pooled and again centrifuged as above. Those fractions with a density between
1 .046 and 1 .054 g/cm3 were pooled and dialyzed.
Ion Exchange Chromatography. LDL of 1 .050±0.004 g/cm3 from RIF+ and RIF- sera were
equilibrated with 0.005 M Tris-HCI, pH 8 .3, and applied to either a 2.5 x 30-cm preparative
column or 0.9 x 10-cm analytical column of DEAE Bio-Gel A (Bio-Rad Laboratories, Richmond,
Cal .) at 20°C and equilibrated with the same buffer. Proteins were eluted in a stepwise fashion
with increasing concentrations of KBrin 0.005 M Tris-buffer, and the effluent was monitored at
280 nm. Fractions were concentrated to the initial sample volume, dialyzed, and assayed for RIF
activity.
Molecular Exclusion Chromatography.
￿
Samples were applied to either a2.5 x 60-cm prepara-
tive column or 0.9 x 10-cm analytical column of Bio-Gel A-5.0, 200-400 mesh (Bio-Rad Laborato-
ries) at 20°C andequilibrated with PBS. Theeffluent was monitored at 280 nm, andfractions were
collected, concentrated, and assayed for RIF activity.
Immunochemical Characterization ofRIF.
￿
Association of RIF activity with specific molecules
was analyzed in double antibody immunoprecipitation assays . Heat inactivated antisera specific
for humanserum proteins including rabbit and goat antisera to albumin, IgG, IgA, IgM, polyva-
lent immunoglobulin, transferrin, alpha-1 antitrypsin, haptoglobin, fibrinogen, and beta lipopro-
tein (Meloy Laboratories Inc., Springfield, Va.), as well as with antisera to hepatitis B surface
(HBsAg) and core (HBcAg) antigens, were employed. Aliquots (100 Jul) of a pool of RIF+ serum,
diluted to approximately 80% ofmaximum RIFactivity (1 :3), was added to 20 Al of each antiserum
and incubated 1 hat 37°C and 18 hat 4°C. 20 gl ofheat-inactivated precipitating antiserum, either
goat antirabbit gamma globulin or rabbit antigoat gamma globulin, was added, and incubation
wascontinued for an additional 24 h at 4°C . After centrifugation at 7,000g for 10 min (Microfuge,
Fisher Scientific Co., Pittsburgh, Pa.), the supernates were assayed for residual (free) RIF
activity, and the percent RIF bound was calculated.
Similar binding studies were performed using purified RIF diluted to approximately 80% of
activity (20 ng/ml). Antisera to the apolipoproteins A,, A, B, C,_, C,, and D (kindly provided by
Dr. P. Alaupovic, Oklahoma Medical Research Foundation, Oklahoma City, Okla.) were also
employed. These antisera have been shown to be specific for the specific apolipoproteins by
Ouchterlony and immunoelectrophoretic analyses (12).FRANCIS V. CHISARI AND THOMAS S. EDGINGTON
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Additional characterization of RIF and its equivalent biologically inactive lipoprotein fraction
from normal serum was achieved by double diffusion in 1% agarose gels using antisera to alpha
lipoprotein and beta lipoprotein (Meloy Laboratories Inc., Springfield, Va.).
Antisera to RIF and the equivalent RIF negative material were raised in adult male New
Zealandwhiterabbits accordingto the followingschedule : an initial injection of 1 pg of immuno-
gen in complete Freund's adjuvant wasmade into thepopliteal lymph nodes. This wasfollowed at
2-wk intervals by multiple intracutaneous paraspinal injections of the immunogen in complete
Freund's adjuvant. The antisera obtained were compared in double diffusion experiments with
antisera to alpha and beta lipoproteins, as well as with antisera to specific apolipoproteins
provided by Dr. P. Alaupovic.
RIF Effect on E Rosette Function.
￿
The dose response of RIF on E rosette function of lympho-
cytes was determined as for the RIF assay usingRIF* and RIF- sera and purified RIF diluted in
PBS, fetal calf serum, and in RIF- humanserum. Kinetics ofinhibition of E rosette function was
determined after incubation with normal lymphocytes for varying periods at 37°C. The lympho-
cytes were washed and assayed for E rosette function as described above.
Recovery from RIF effect wasassayed after addition of 50 tal purified RIF at 20 ng protein/ml to
lymphocytes (4 ng RIF protein/ml culture) and incubated for 24 h. The lymphocytes were washed
three times in complete media and returned to culture in the absence of RIF, and E rosette
function was assessed at intervals thereafter.
Binding ofRIF by Lymphocytes.
￿
100-Al aliquots ofpurified RIF at 20 ng protein/ml incomplete
medium was added to varying numbers of lymphocytes in microcentrifuge tubes. The cells were
suspended and incubated for 1 h at 37°C and then removed by centrifugation at 7,000 g . The
percent RIF activity remaining in the supernates was determined from standard dilutions of
purified RIF, and percentboundwas calculated. The maximumnumber of RIF moleculescapable
ofbeingbound per lymphocyte wasdetermined by leastsquare matched linear regression analysis
ofRIFboundperlymphocyte vs. thebound/free ratioofRIF. Theestimated mean bindingconstant
was calculated from k = [RIF-R]/[RIF][R], where [R] represents the molar concentration of
lymphocyte receptors for RIF.
Mixed Lymphocyte Reactions. Two-way, mixed lymphocyte cultures were performed by a
modification of the microculture method of Thurman et al. (13). Peripheral blood lymphocytes
were isolated from two standard unrelated donors by the Ficoll-Hypaque method as described
above. Cellswere adjusted to 1.0 x 101/mlin complete media; and equal volumes from each donor
were mixed. Aliquots (200 p.l) were dispensed into microculture plates containing 20 pl of either
RIF* serum, RIF- serum, fetal calfserum, purified RIF, or the equivalent material isolated from
RIF- serum. The cultures were incubatedfor 96 hat 37°C in a humidified atmosphere containing
5% C02 in air at the end of which 1 jXi of [3H]methylthymidine (sp act 2 Ci/mmol) was added.
After 18 h incubation the cultures were harvested into glass fiber filters utilizing a multiple
automated sample harvester (MASH-II, Microbiological Associates, Bethesda, Md.). The filters
were dried, dispensed into vials containing 3 ml of scintillation cocktail composed of Omnifluor
(New England Nuclear, Boston, Mass.) in toluene, and counted. Experiments were performed in
triplicate.
Mitogen Responsiveness.
￿
The DNAsyntheticresponse of lymphocytes to stimulation by phyto-
hemagglutinin (PHA) was assayed by the microculture method of Hartzman et al. (14) using a
system similar to that described above for the mixed lymphocyte reaction. Peripheral blood
lymphocytes were suspended in complete culture media at a concentration of 0.5 x 106/ml.
Aliquots of 200 p.l were dispensed into microculture plates which contained 20 Wl of RIF` sera,
fractionsor control materials, and 1 pl (0.6 Ixg) of PHA-P (Difco Laboratories, Detroit, Mich.), an
optimal concentration, wasadded. After 48 h, 4 pCi of ['H]methylthymidine (50 mCi/mmol) was
added, and incubation was continued foran additional 18 h. The cells were harvested and counted
as described above. Assays were performed in triplicate.
Lipoprotein Electrophoresis.
￿
Lipoprotein electrophoresiswasperformedon cellulose acetate in
0.025 Mbarbital buffer, pH 8.8, on aBeckman Model R-101 Microzone apparatus. Afterelectropho-
resis at 12.8 V/cm for 45 min, the strips were dried and stained with fat red.
Immunoelectrophoresis.
￿
Microimmunoelectrophoresis was performed in 1% agarose on 1 x 3
inch microslides at 6V/cm for 80 min. Precipitin patterns were developedwith 100 pl of antiwhole
human serum (Meloy Laboratories) by incubation for 24 h at room temperature.
HBsAg .
￿
HBsAg wasassayed by the solid phaseassay (Ausria, Abbott Laboratories, Chicago,1096
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Ill.) using 0.1 ml aliquots of diluted serum or serum fractions (15).
Protein.
￿
Protein was determined by the method of Lowry et al. (16).
Results
Physical Characteristics ofRIF.
￿
It was initially observed that RIF activity,
present in RIF+ sera, could be effectively segregated from serum proteins by a
single analytical flotation at 189,000 g. RIF was recovered in the low-density
fraction (<1.10 g/cm3), and this fraction was enriched in lipoproteins of beta ()3)
and prebeta (pre-,Q) electrophoresic types (Table I) consistent with enrichment in
LDL and VLDL. Immunoelectrophoretic analysis of RIF+ fractions 1 and 2
revealed a single serum protein are with beta mobility ; and a line of identity was
observed in gel double diffusion with the single precipitin line formed between
serum and anti-)3-lipoprotein . HBsAg was absent from the low-density RIF+
fractions and was recovered in fraction 6 with the majority of serum proteins.
Single analytical flotation followed by isopycnic banding of RIF+ sera or
serum pools led to recovery of RIF in fractions of densities of 1.050 to 1 .059 g/cm3
(Fig. 1) . The distribution of RIF activity was not proportional to the distribution
of protein, but was recovered in the lower density portion of the LDL fraction.
Equivalent fractions from RIF- sera were devoid of RIF activity.
Standard classes of lipoproteins were isolated from RIF+ and RIF- serum by
sequential lipoprotein flotation. RIF activity was recovered only from the LDL
and VLDL fractions of RIF+ sera. These fractions were pooled, adjusted to a
density of 1 .050 with KBr, and subjected to isopycnic density gradient ultracen-
trifugation ; RIF activity was recovered in the first run over a range of 1.039 to
1 .062 g/cm3. A second isopycnic banding led to improved resolution, and RIF
activity was completely recovered with a restricted density of 1 .050±0 .004 g/cm3
in KBr. Proteins other than a-lipoproteins were not demonstrable by lipoprotein
electrophoresis and immunoelectrophoresis.
Isolation of RIF.
￿
The uniquely restricted density of RIF was exploited to
isolate RIF-enriched lipoprotein from 200-ml samples of RIF+ serum or control
RIF- serum. After three sequential isopycnic bandings fractions with densities
between 1 .046 and 1.054 g/cm3 free of contaminating VLDL, high-density lipopro-
tein (HDL) and conventional serum proteins were pooled and fractionated by ion
exchange chromatography on DEAE Bio-Gel. Protein was eluted in a stepwise
fashion with increasing concentrations of KBr varying from 0.01 M to 1.0 M.
Two broad protein fractions were recovered (Fig. 2) . RIF activity was eluted only
between 0.02 and 0.04 M KBr, the frontal aspect of the first peak, a minor
proportion of the total recovered LDL. Equivalent protein fractions were re-
covered from the RIF- serum but were devoid of RIF activity.
LDL of 1.046-1.054 g/cm3 was heterogeneous with regard to size, when sub-
jected to analytical molecular exclusion chromatography on A-5 agarose col-
umns. A minor peak approximating the void volume possessed RIF activity,
whereas the major included peak was devoid of detectable RIF activity. When
RIF+ fractions recovered from preparative ion exchange chromatography were
subjected to molecular exclusion chromatography, RIF activity was again re-
coverable at the first, and only detectable, protein peak (Fig. 3). The volume of
elution coincided with typical normal LDL (estimated mol wt of 3 .5 x 106) (17).FRANCIS V. CHISARI AND THOMAS S. EDGINGTON
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TABLE I
Ultracentrifugal Flotation ofRIF*
* Single analytical flotation at 189,000 g in KBr of a RIF+ serum pool.
$ Expressed as 1-4*, where 4+ is equivalent to serum pool.
Fraction Number
Serum proteins present
08
1 .08
1 .05
1 .04
FIG. 1.
￿
Single analytical isopycnic banding of the RIF+ lipoprotein fractions of serum
previously subjected to a single analytical flotation. The sample was adjusted to 1.063 g/cm3
and centrifuged at 114,000g for 72 hat 20°C . RIF activity wasrecovered only from the lower
density (1.050-1.059 g/cm3) portion of the major LDL band (1.050-1.070 g/cm3).
This material, prepared from a single 200 ml high titer RIF+ serum, was
concentrated to 2 ml, a protein concentration of 20 gg protein/ml.
Dose-Response Characteristics andRecovery ofRIF.
￿
The quantitative recov-
ery of RIF activity from starting serum was evaluated by RIF assays employing
serial dilutions of purified RIF and starting serum. The maximum absolute
inhibition produced by the serum and the purified RIF was identical, the dose
responses were parallel, and both produced approximately 50% absolute inhibi-
tion of the E rosette positive cells relative to saline and normal control serum.
Results were expressed as percent of maximum attainable inhibition (Fig. 4).
50% relative inhibition was produced by the purified RIF preparation at a
dilution of 1 :6,561, equivalent to a concentration of 170 pg protein in the sample
and 690 pg protein/ml final concentrationin the cultures. The use ofRIF- serum
rather than PBS or fetal calf serum as diluent had no effect on the dose response
curve. Based on an average mol wt of 3.5 x 101, and 20% protein for LDL (17, 18),
Fraction RIF
% inhibition
HBsAg$
Lipoprotein
electrophoresis
Immuno-
electrophoresis
1 32 0 /3, pre-R /3 lipo
2 30 0 /3 nil
3 0 0 /3, a nil
4 0 0 (3, a nil
5 0 1+ a albumin
6 0 4+ a albumin +
other
proteins1098
￿
ROSETTE INHIBITORY FACTOR
FIG. 2 .
￿
Fractionation of partially purified RIF by analytical ion exchange chromatogra-
phyon DEAE-Bio-Gel . An aliquot of RIF+ LDLof density 1 .050±0 .004 g/cm 3 in 0.005MTris-
buffer pH 8.3 was applied to a column in thesame buffer . Stepwise elution was carried out
with increasing concentrations ofKBr. RIF activity was demonstrated only in the 0.02 M-
0.04 MKBr eluates .
FIG. 3.
￿
Molecular exclusion chromatography on Bio-Gel A-5 ofpartially purified RIF from
ionexchange chromatography . A single proteinpeak close to the void volume ofthecolumn
and equivalent to that of normal LDL is demonstrated . RIF activity is restricted to the
protein peak .
an estimated concentration ofpurified RIF required for 50% inhibition is approxi-
mately 1 x 10- `2 M in culture . Based on protein recovery, isolation of RIF
involved a 300,000-fold purification from serum . The ratio of the reciprocals of
the dilutions of purified RIF and original serum required for 50% RIF activity
indicated a 436% recovery of RIF activity .
Immunochemical Characterization ofRIF .
￿
The presence of RIF activity on
individual human serum proteins was analyzed in double antibody immunopre-
cipitation assays . Purified RIF and the original RIF+ serum were diluted in PBS
or normal (RIF-) human serum at 20 ng protein/ml and 1 :3, respectively .FRANCIS V. CHISARI AND THOMAS S. EDGINGTON
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FIG. 4.
￿
Dose-response characteristics of purified RIF and the starting serum. Results
expressed as percent ofmaximum inhibition .
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Incubation of these samples with antisera to human albumin, immunoglobu-
lins, alpha-1 antitrypsin, HBsAg, HBcAg, transferrin, haptoglobin, or fibrino-
gen and subsequent precipitation with second antibody was associated with no
loss ofRIF activity . In contrast, incubation with antibeta lipoprotein completely
removed RIF activity from both purified RIF and RIF+ serum .
Similar experiments were performed with antisera to each of the human
apolipoproteins . RIF was bound by antisera to R-lipoproteins and to apoproteins
A , B, and C,, but not by antisera to apoproteins A, C,_, or D (Table II) . The
antigenic determinants of both alpha lipoproteins and beta lipoproteins, LP-A
and LP-B, were demonstrated by Ouchterlony analysis of the RIF preparation as
well as in its biologically inactive counterpart from normal serum . Further-
more, antisera prepared to each of these isolated substances give reactions of
identity with antisera reactive with LP-A and LP-B . This body of evidence
suggests that RIF activity is expressed either by an association complex of
different classes of lipoproteins or by a unique hybrid lipoprotein possessing
each of these selected protein chains . The presence of similar apoproteins in the
biologically inactive lipoprotein fractions from normal serum suggests that RIF
activity may be due to conformational properties of the complex or other
structural aspects that remain to be elucidated .
Kinetics ofRIF Effect In Vitro .
￿
Sera from six RIF+ and five RIF- individuals
were used to characterize the temporal kinetics of the effect ofRIF on E rosette
function (Fig . 5) . No effect offive of the six RIF+ sera was observed before 4 h of
incubation with the lymphocytes . RIF activity reached a peak at 24 h and
remained relatively unchanged during the following 24 h . One of the six RIF+
sera differed in that it exerted a significant inhibitory effect as early as 2 h after
incubation ; however maximal inhibition was not observed until 24 h .
Dilution of this latter serum 1 :5 with PBS led to an initial 4 h lag period and a
24h peak effect similar to the curves obtained with the other five RIF+ sera . No
serum thus far tested has exerted more than a 40-50% inhibition of absolute E
rosette formation regardless of the duration of incubation, time required for
initial inhibition, or absolute concentration of RIF .
Lymphocyte Recovery .
￿
The time required for lymphocytes to recover from
RIF inhibition ofE rosette function was evaluated in vitro . After 24 h incubation1100
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TABLE II
Immunochemical Analysis of the Apolipoprotein Composition of
RIF
* Calculated from 100- percent supernatant RIF.
f Purified RIF preparation at 20 ng protein/ml.
§ Normal rabbit serum (NRS) or normal goat serum (NGS).
oo ----I -- ~~_
48
Hours in Culture
FIG. 5. Temporal kinetics of functional defectiveness of lymphocytes in respect to E
rosette function. Six RIF+ (-) and five RIF- sera (-----) are illustrated, and results are
expressed as percent relative inhibition at various intervals in culture. The accelerated
effect ofhigh titered RIF+ serum ( ") is normalized by dilution 1 :5.
with RIF at 4 ng protein/ml, the lymphocytes were washed, returned to culture
in the absence of RIF, and assayed for E rosette function at various periods
thereafter (Fig. 6) . Partial recovery was observed as early as 1 h after washing,
proceeded in a linear fashion, and was complete at 6 h. It appears that the
continued presence of RIF may be required for functional inhibition of E rosette
function.
RIF Binding to Lymphocytes .
￿
The binding of RIF at 20 ng protein/ml was
examined by assay of residual free activity after 1 h incubation. Binding of RIF
occurs rapidly and was observed as early as 15 min after exposure to lympho-
cytes and appeared complete by 1 h. RIF was bound by lymphocyte preparations
and the quantity bound was directly proportional to the number of cells (Fig. 7)
with a correlation coefficient r = -0.99. The number of receptor sites for RIF
Antiserum
RIF activity
PBS diluentt
bound*
NHS diluentt
Anti-Ar 7.7 5.1
Anti-Ar, 100 100
Anti-13 100 100
Anti-C1,11 0 6.3
Anti-C11, 95.8 100
Anti-D 2.6 0
NRS§ 0 0
NGS§ 0 0FRANCIS V. CHISARI AND THOMAS S. EDGINGTON
FIG. 6.
￿
Temporal kinetics of recovery of lymphocytes from RIF-induced inhibition of E
rosette function. Lymphocytes were incubated in complete culture media containing puri-
fied RIF (4 ng protein/ml) for 24 h. Thelymphocytes were washed andreturned to culture in
the absence of RIF, and E rosette function was assayed at various intervals. Results
expressed relative to percent of maximum inhibition observed at 0 h.
Recovery Period jhj
2 3 4 5
6 t
B
￿
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Lymphocytes x10 5) Incubated with Purified RIF
500 1000
￿
1500
￿
2000
RIF Bound/Free per lymphocyte
FIG. 7.
￿
Thebinding of RIF by lymphocytes. In the top panel an aliquot ofpurified RIFat
20 ng protein/ml was incubated with varying numbers of lymphocytes for 1 hat 37°C in avol
of 100 Al . Percent of RIF bound was calculated from the quantity of residual free RIF
activity of the supernates. In thelower panel thenumber ofreceptors for RIF was estimated
from saturation studies. Binding was calculated as molecules RIF/lymphocyte andplotted
against the bound/free ratio. Least square matchedlinear regression analysis exhibits good
agreement of points (r = -0.98, P < 0.01) with a saturation level of 2,900 molecules of
RIF/lymphocyte. An equal number of receptors can be postulated on thebasis of aunimolar
ratio of RIF and receptor.
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was estimated from binding profiles by plotting molecules RIF bound/cell
against the bound/free ratio ofRIF activity (Fig. 7). Four point analysis provided
a straight line linear regression (r = -0.98, P <0.01) and an estimated 2,900
receptor sites per cell based on an estimated mol wt of 3.5 x 106 and a 20%
protein composition of RIF. The mean binding constant (k) estimated at 50%
bindingofRIFby 5.2 x 105 lymphocytes under these conditions is approximately1102
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TABLE III
Effects of RIF on the Mixed Lymphocyte Reaction
9.3 x 1010 1/mol, well in accord with a specific interaction between RIF and a
specific lymphocyte surface receptor.
Effects of RIF on Other Parameters of Lymphocyte Function .
￿
RIF+ serum
was mildly inhibitory in the two-way lymphocyte reaction when compared with
normal RIF- serum (Table III). However, both purified RIF and the equivalent
preparation from RIF- serum at 180 ng protein/ml (approx. 2.6 x 10-1 M) were
highly inhibitory and to an equal degree. At 2.6 x 10-' M neither preparation
induced a significant inhibition of thymidine incorporation. Neither purified
preparation nor the original RIF+ and RIF- sera at equivalent concentrations
inhibited thymidine incorporation of lymphocytes after stimulation by PHA.
Discussion
In the present study, we have isolated andcharacterized anew immunoregula-
tory factor found in sera from patients with hepatitis B virus infection and
demonstrated that it is a discrete and unique serum beta lipoprotein. This
factor, RIF, modulates the capacity of human T lymphocytes to form rosettes
with E, a functional marker of these cells. The pathological association of RIF
with chronic hepatitis after hepatitis B virus infection suggests that RIF may
influence immunological aspects of tissue injury associated with this viral
infection. RIF is not restricted to this viral infection and may influence the
pathogenesis of other diseases as well.4 Although RIF is identified by reference
to its capacity to modulate a specific T lymphocyte function in vitro, it also
appears to be active in vivo since: (a) T lymphocytes functionally deficient in E
rosette capacity occur in the peripheral blood of patients whose serum contains
RIF, and (b) when these lymphocytes are incubated in the absence of autologous
RIF+ serum, they reacquire normal E rosette function (9).3
Because of its low density, RIF canbe readily distinguished by simple ultra-
Curtiss, L. K., and T. S. Edgington. Unpublished observations.
Test substance Concentration Response
cpm %
Fetal calf serum 20% 21,782 ± 618 100
PBS 20% 17,683 t 590 81
RIF' serum 20% 11,495 t 578 53
Purified RIF' 180 ng protein/ml 1,333 ± 68 6
18 ng protein/ml 20,186 ± 643 93
RIF- serum 20% 24,887 t 721 114
Purified RIF- 180 ng protein/ml 1,583 ± 92 7
18 ng protein/ml 22,630 ?- 706 104FRANCIS V. CHISARI AND THOMAS S . EDGINGTON
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centrifugation from most other serum constituents shown to influence lympho-
cyte function in vitro including immunoglobulins (19), corticosteroids (20), immu-
noregulatory alpha globulins (21), glycoproteins (22), and C-reactive protein
(23) . RIF activity is found at a density less than 1 .10 g/cm3 which contains
primarily lipoproteins ofLDL and VLDL classes . In contrast to the general class
of LDL with a density of 1 .006-1.063 g/cm3 , RIF has a restricted density of
1.050±0.004 g/cm3 , and it constitutes only a very minor component of serum
LDL . When preparations obtained by repeated sequential isopycnic density
gradient ultracentrifugation were subjected to ion exchange and molecular
exclusion chromatography, the size ofRIF was indistinguishable fromLDL with
an estimated mol wt of 3 .5 x 10 6 (17), but was restricted to a weakly anionic
subset of these molecules . These observations suggest that RIF activity is
associated with a unique species ofLDL distinct from the general population of
molecules of this lipoprotein class .
Isolation of RIF was associated with recovery of approximately four times
more activity than initially present, suggesting that the increased RIF activity
results from either modification of an inactiveform or the presence of inhibitors .
RIF may be present not only in an active form but also in a precursor form that
is activated by mechanisms such as modulation of tertiary or quaternary struc-
ture during isolation . Alternatively, RIF might be damped in whole serum by
the presence of competitive inhibitors or agents independently capable of aug-
menting E rosette function . Inhibitors were not demonstrable in normal serum ;
however, their presence in RIF + sera can not be excluded .
Evidence to support the former hypothesis is provided by immunochemical
assays which demonstrate that the biological activity of RIF is directly associ-
ated with and must be resident on molecules containing three different apolipo-
proteins : A , B, and C, . This suggests that RIF activity may be due to either
certain properties generated by the association of these three lipoproteins into a
lipoprotein complex or the formation of a hybrid species of lipoprotein . Lipopro-
tein association complexes have been described in normal human serum (24) but
usually occur at densities less than 1 .019 g/cm3 . Because of its unique density we
favor the concept that RIF is an unusual hybrid lipoprotein containing apolipo-
proteins of the A, B, and C classes .
The extraordinary functional potency of RIF supports the specificity of its
effect and is consistent with its in vivo activity . Employing reasonable assump-
tions concerning molecular weight, lipid:protein ratio, and purity of prepara-
tions it is estimated that biological activity is observed at RIF concentrations as
low as 1 x 10- '2M . Saturation studies suggest the availability of approximately
2,900 receptors sites per cell and a binding constant (k) of approximately 9 .3 x
10'° liters/mol . The high affinity of this interaction suggests that the recovery of
lymphocytes from the influence of RIF does not reflect removal of bound RIF,
but rather results from removal of available "free" RIF . This conclusion in turn
suggests that RIF must be irreversibly utilized in exerting its biological effect .
The recovery rate of lymphocytes from RIF indicates a functional half-life of
approximately 1 1/z h . This remarkable potency and rapid turnover underscores
the biological significance of this factor .
The capacity of lipoproteins to regulate cellular metabolism has recently been1104
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documented by Goldstein and Brown (25). They have demonstrated the exist-
ence on human fibroblasts of a cell surface receptor required for binding of
plasma LDL. It appears that the regulation of the sterol content of cells,
including the rates of uptake, esterification, and synthesis of cholesterol is
modulated by the interactionof LDL with this receptor. The effect on cholesterol
biosynthesis appears to follow inhibition of the synthesis of 3-hydroxy-3-methyl-
glutaryl coenzyme A reductase, a rate limiting enzyme in the cholesterol
biosynthetic pathway (25) .
Thebiological activity of RIF apparently depends upon bindingto the lympho-
cyte followed by initiation of the events that subsequently lead to inhibition of E
rosette function. Despite rapid binding, more than 4 h is required for reduction
in the number of observed E rosette positive lymphocytes, and maximal effect is
not observed for 18-24 h. This temporal sequence suggests that RIF inhibits E
rosette function by modification of metabolic events rather than by direct steric
hindrance at the lymphocyte surface. The continued presence of RIF, requisite
for its biological effect, is also well in accord with a similar active regulatory
role.
The functional expression of the RIF effect may be dependent on modification
of the rate of synthesis, membrane incorporation, or loss ofE receptors. Since (a)
the binding of a variety of other proteins to lymphocyte surface membranes is
known to activate the adenyl cyclase-cyclic AMP system; and (b) elevated
intracellular cyclic AMP levels inhibit E rosette function (2, 3), as well as other
lymphocyte functions (26-28), modulation of the cyclic nucleotides system might
be responsible for the biological activity of RIF.
RIF appears to inhibit E rosette function of only a subpopulation ofT lympho-
cytes, sincegreater than 40-50% relative inhibition of E rosette function hasnot
been observed, even with a 1,000-fold excess of RIF. The number of lymphocytes
capable of forming "active" rosettes according to the method of Wybran and
Fudenberg (6) is normal in RIF+ patients whereas the total number of E rosette
positive lymphocytes is reduced. 3 This suggests that lymphocytes that require a
longer incubation period for the full expression of E rosette capacity are the cells
that are inhibited by RIF. Whether this relates to density of receptors for E,
lower affinity of receptors, availability of receptors for RIF, or susceptibility to
inhibition remains to be established.
The available evidence suggests that RIF may represent an abnormal associa-
tion complex or a hybrid form of lipoprotein incorporating an unusual set of
apolipoproteins. Since thesesame speciesexist separately andin various associa-
tion complexes in RIF- sera, the biological properties must be attributed to the
nature of the complex rather than the apolipoproteins per se . The role played by
the lipid moieties of RIF must be investigated, particularly in light of studies
suggesting that fatty acids may influence lymphocyte function (29).
The observation that an abnormal lipoprotein, lipoprotein X, is found in the
serum of patients with obstructive jaundice (30) is of interest since it appears to
be an abnormal association complex of apolipoproteins, lipids, and other serum
proteins . It is possible that hepatocellular injury may induce alterations in
hepatocyte biosynthetic pathways that result in the synthesis of normal apolipo-
proteins which associate with lipids and other proteins in abnormal arrays orFRANCIS V. CHISARI AND THOMAS S. EDGINGTON
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result in the formation of unusual hybrid molecules such as RIF. Alternatively,
RIF may be a normal intracellular constituent of the hepatocyte and may be
released into the circulation as a consequence of hepatocellular necrosis. Indeed
Schumacher et al . have identified a factor in normal human liver which is
capable of inhibiting the response of lymphocytes to phytohemagglutinin and
allogeneic cells (31).
Summary
Rosette inhibitory factor, RIF, previously described in serum from patients
with hepatitis B virus infection, has been isolated and identified as a minor
species of 8-lipoprotein of the low-density lipoprotein (LDL) class. It is unrelated
to hepatitis B virus proteins or particles. Although discrete by reference to
charge and density (1 .050±0.004 g/cm3), RIF appears to be a complex macromo-
lecular structure containing apolipoproteins A, B, and C . Greater than 400%
recovery is achieved upon 300,000-fold purification from RIF+ sera suggesting
activation of a precursor form that is not present in normal serum.
RIF inhibits E rosette function of T lymphocytes in vitro with a lag period of
approximately 4 h and maximal effect at 24 h consistent with a metabolically-
induced event. RIF is functionally active at concentrations of 1 x 10-'z M or
greater, rapidly binds to lymphocytes, and has a functionally effective half-life
of approximately 1.5 h. Approximately 2,900 receptors for RIF appear to be
present per cell and a high mutual affinity is apparent (k - 9 x 101° liters/mol) .
RIF has no detectable effect on mitogen (PHA) responsiveness of lymphocytes,
but inhibits the capacity of lymphocytes to respond to histoincompatible cells in
vitro at concentrations greater than 10-5 M. Equivalent RIF- lipoprotein frac-
tions from normal serum are equally inhibitory in the mixed lymphocyte reac-
tion suggesting that this effect is not directly attributable to RIF activity.
These data indicate that RIF is a unique and functionally specific species of
LDL that represents either an association complex of lipoproteins or a hybrid
molecule of unusual composition . The association of this factor with viral-
induced hepatocellular injury underscores the need to elucidate its structure and
function in greater detail .
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